医薬品検査機市場規模、シェア、動向、2031年までの世界予測

医薬品検査機市場は、2026年の11億4,000万米ドルから2031年には16億2,000万米ドルに成長し、年平均成長率（CAGR）7.2%に達するとMarketsandMarketsでは予測しています。アンプルおよびバイアル市場の急成長は、厳格な品質管理と検査基準を必要とする注射剤、バイオ医薬品、ワクチン、および無菌医薬品の生産拡大によって牽引されています。これらの容器は非常に繊細であり、微粒子混入、外観上の欠陥、充填量の不均一、亀裂、密封性の不備などを検出できる高度な検査技術が求められます。マシンビジョンや高解像度画像処理技術を統合したAI搭載の検査システムは、正確なリアルタイム分析を実現し、欠陥検出能力を向上させます。非経口投与製剤（注射剤など）への需要の高まりに加え、規制要件の厳格化や医薬品製造の自動化の進展が、アンプルおよびバイアル向け高度検査システムの導入を加速させています。さらに、製造業者は業務効率の向上、製品回収（リコール）の最小化、そして製品の安全性を確保するために、高速検査ソリューションへの投資を積極的に進めています。

調査対象範囲

本レポートは、医薬品検査機市場を評価し、構成要素、機器タイプ、包装形態、製剤形態、エンドユーザー、地域などの各種セグメントに基づいて、市場規模および将来の成長性を推定しています。また、主要企業の競争分析に加え、各社の企業概要、製品ラインナップ、最近の動向、主要な市場戦略についても取り上げています。

本レポートを購入するメリット

本レポートは、医薬品検査機市場全体および各サブセグメントの推定売上データを提供することで、市場のリーダー企業や新規参入企業を支援します。また、ステークホルダーが競争環境を把握し、自社の事業の最適なポジショニングや適切な市場参入戦略（Go-to-Market戦略）の策定に向けた知見を深める一助となります。さらに、市場の動向を理解する上で役立つ情報として、市場に影響を与える促進要因、阻害要因、障壁、および機会に関するデータも提供します。

本レポートでは、以下の点に関する知見を提供します。

主要な推進要因（AIやマシンビジョンを活用した検査システムの導入拡大、医薬品製造量の増加、厳格な規制遵守と品質保証への注力、自動検査ソリューションへの需要増、患者の安全確保と不良品削減への関心の高まり）、阻害要因（高度な検査システムの導入・保守コストの高さ、既存の製造インフラとの統合の複雑さ）、機会（インダストリー4.0やスマートマニュファクチャリングの導入拡大、新興国における医薬品検査ソリューションの需要増）、および課題（高度なシステムを運用できる熟練専門家の不足、高い検査精度と誤不合格率の最小化の両立）の分析

• 製品の改良・革新：世界の医薬品検査機市場における新製品の投入や今後のトレンドに関する詳細情報
• 市場の発展：製品、用途、エンドユーザー、地域別の有望な成長市場に関する包括的な知見と分析
• 市場の多角化：世界の医薬品検査機市場における新製品、市場拡大、技術進歩、投資動向に関する包括的な情報
• 競合状況の評価：世界の医薬品検査機市場における主要企業の市場シェア、成長戦略、製品・サービス、能力に関する詳細な評価

Report Description

The pharmaceutical inspection machines market is projected to reach USD 1.62 billion by 2031 from USD 1.14 billion in 2026, growing at a CAGR of 7.2%.

The rapid growth of the ampoules and vials segment is driven by increasing production of injectable drugs, biologics, vaccines, and sterile pharmaceutical products that require stringent quality control and inspection standards. These packaging formats are highly sensitive and demand advanced inspection technologies capable of detecting particulate contamination, cosmetic defects, fill-level inconsistencies, cracks, and seal integrity issues. AI-enabled inspection systems integrated with machine vision and high-resolution imaging technologies provide accurate real-time analysis and improve defect detection capabilities. Rising demand for parenteral formulations, coupled with stricter regulatory requirements and increasing adoption of automated pharmaceutical manufacturing, is accelerating the deployment of advanced inspection systems for ampoules and vials. Additionally, manufacturers are increasingly investing in high-speed inspection solutions to enhance operational efficiency, minimize recalls, and ensure product safety.

Based on Component: One of the key factors driving the growth of the software and vision system segment in the Pharmaceutical Inspection Machine market is the increasing adoption of advanced machine vision, AI, and sensor technologies. Inspection systems comprise components such as cameras, sensors, robotics, conveyors, software platforms, and data analytics tools that work together to ensure accurate detection and quality assurance. High-performance imaging systems and AI-enabled software improve the identification of particulate contamination, cosmetic defects, fill-level variations, and packaging inconsistencies with greater precision. In addition, advanced software solutions reduce false rejection rates and support real-time monitoring and process optimization. As pharmaceutical manufacturers continue investing in automation and quality compliance, demand for intelligent inspection components is increasing, strengthening their role in modern pharmaceutical manufacturing environments.

Based on Formulation: One of the major factors driving the dominance of injectable and sterile formulation segments in the Pharmaceutical Inspection Machine market is the critical need for stringent quality control and patient safety. Pharmaceutical inspection machines are extensively used for formulations such as injectables, biologics, tablets, capsules, ophthalmic products, and liquid formulations to detect defects, particulate contamination, fill-level inconsistencies, and packaging errors. Injectable and sterile products require highly precise inspection due to strict regulatory requirements and the high risk associated with contamination. In addition, the growing production of biologics, prefilled syringes, and complex drug formulations has increased demand for advanced inspection systems. As pharmaceutical manufacturers continue to prioritize product integrity and compliance, inspection requirements across diverse formulation types are driving sustained market growth.

North America’s well-established pharmaceutical manufacturing ecosystem plays a crucial role in driving the adoption of pharmaceutical inspection machines. The region has a strong presence of leading pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), and advanced production facilities that require stringent quality control and regulatory compliance. Pharmaceutical manufacturers in the U.S. and Canada increasingly invest in automated inspection technologies, machine vision systems, and AI-enabled quality assurance solutions to enhance operational efficiency and ensure product safety. Additionally, strict regulatory frameworks and quality standards encourage the deployment of advanced inspection systems across production lines. The presence of strong R&D capabilities, high healthcare expenditure, and continuous investments in manufacturing modernization further support market growth. This robust pharmaceutical ecosystem ensures sustained demand and widespread adoption of pharmaceutical inspection machines across the region.

A breakdown of the primary participants (supply-side) for the pharmaceutical inspection machine market referred to in this report is provided below:

• By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
• By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
• By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the pharmaceutical inspection machine market are market Körber AG (Germany), Mettler Toledo (US), Omron Corporation (Japan), Cognex Corporation (US), Stevanato Group (Italy), Antares Vision S.p.A. (Italy), Optel Group (Canada), Syntegon Technology GmbH (Germany), Jekson Vision (India), ACG (India), Brevetti CEA S.p.A. (Italy), Roquette Frères (France), Toflon Life Science (China), Prodieco (Ireland), WIPOTEC GmbH (Germany), CMP Pharma S.R.L. (Italy), Keyence Corporation (Japan), Cassel Messtechnik GmbH (Germany), Thermo Fisher Scientific Inc. (US), Loma Systems (UK), VITRONIC Dr.-Ing. Stein Bildverarbeitungssysteme GmbH (Germany), Minebea Intec GmbH (Germany), Marchesini Group S.p.A. (Italy), N.K.P. Pharma Pvt. Ltd. (India), and Span Systems (India).

Research Coverage

The report evaluates the pharmaceutical inspection machine market and estimates the market size and future growth potential of this market based on various segments, including by component, type, packaging type, formulation, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants in the market with data on the nearest approximations of the revenue numbers for the overall, the pharmaceutical inspection machine market, and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies.  The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

Analysis of key drivers (increasing adoption of AI- and machine vision-based inspection systems, rising pharmaceutical manufacturing output, growing emphasis on stringent regulatory compliance and quality assurance, rising demand for automated inspection solutions, increasing focus on patient safety and defect reduction), restraints (high implementation and maintenance costs of advanced inspection systems, complex integration with existing manufacturing infrastructure), opportunities (growing adoption of Industry 4.0 and smart manufacturing, rising demand for pharmaceutical inspection solutions in emerging markets), and challenges (shortage of skilled professionals for operating advanced systems, managing high inspection accuracy while minimizing false rejection rates)

• Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global pharmaceutical inspection machines market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global pharmaceutical inspection machines market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global pharmaceutical inspection machines market

Table of Contents

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 STUDY SCOPE 33
1.3.1 SEGMENTS COVERED & REGIONAL SCOPE 33
1.3.2 INCLUSIONS & EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 34
1.3.4 CURRENCY CONSIDERED 35
1.4 STAKEHOLDERS 35
1.5 LIMITATIONS 35
1.6 SUMMARY OF CHANGES 36
2 EXECUTIVE SUMMARY 37
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 37
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 40
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 41
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 42
3 PREMIUM INSIGHTS 43
3.1 PHARMACEUTICAL INSPECTION MACHINES MARKET OVERVIEW 43
3.2 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PRODUCT AND COUNTRY (2025) 44
3.3 PHARMACEUTICAL INSPECTION MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 45
3.4 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION (2023–2030) 45
3.5 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 46
4 MARKET OVERVIEW 47
4.1 INTRODUCTION 47
4.2 MARKET DYNAMICS 47
4.2.1 DRIVERS 48
4.2.1.1 Increasing use of inspection machines by pharmaceutical and biotechnology companies 48
4.2.1.2 Rising number of inspection checkpoint mandates 49
4.2.1.3 Technological advancements and stringent regulatory mandates for high-quality products 49
4.2.2 RESTRAINTS 50
4.2.2.1 High initial capital expenditure and recurring maintenance costs 50
4.2.2.2 Increased data security and privacy concerns 50
4.2.3 OPPORTUNITIES 51
4.2.3.1 Increasing outsourcing of manufacturing operations to emerging economies 51
4.2.3.2 Focus on production optimization and high R&D investments 52
4.2.4 CHALLENGES 53
4.2.4.1 Complexities in integrating pharmaceutical inspection machines 53
4.3 UNMET NEEDS & WHITE SPACES 53
4.3.1 UNMET NEEDS IN PHARMACEUTICAL INSPECTION MACHINES MARKET 53
4.3.2 WHITE SPACE OPPORTUNITIES 54
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 56
5 INDUSTRY TRENDS 57
5.1 PORTER’S FIVE FORCES ANALYSIS 57
5.1.1 THREAT OF NEW ENTRANTS 58
5.1.2 THREAT OF SUBSTITUTES 58
5.1.3 BARGAINING POWER OF BUYERS 58
5.1.4 BARGAINING POWER OF SUPPLIERS 58
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58
5.2 MACROECONOMIC INDICATORS 59
5.2.1 INTRODUCTION 59
5.2.2 GDP TRENDS & FORECAST 59
5.2.3 TRENDS IN GLOBAL PHARMACEUTICAL INDUSTRY 60
5.2.4 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 61
5.3 SUPPLY CHAIN ANALYSIS 61
5.3.1 ROLE IN SUPPLY CHAIN 63
5.4 VALUE CHAIN ANALYSIS 64
5.5 ECOSYSTEM ANALYSIS 65
5.5.1 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS 66
5.5.2 END USERS 66
5.6 PRICING ANALYSIS 67
5.6.1 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY PRODUCT 68
5.6.2 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY REGION 69
5.6.3 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY END-USE INDUSTRY 69
5.7 TRADE ANALYSIS 69
5.7.1 IMPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180) 69
5.7.2 EXPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180) 70
5.7.3 IMPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190) 70
5.7.4 EXPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190) 71
5.8 KEY CONFERENCES & EVENTS, 2026–2027 72
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
5.10 INVESTMENT & FUNDING SCENARIO 73
5.11 CASE STUDY ANALYSIS 74
5.12 IMPACT OF 2025 US TARIFFS ON PHARMACEUTICAL INSPECTION MACHINES MARKET 76
5.12.1 INTRODUCTION 76
5.12.2 KEY TARIFF RATES 77
5.12.3 PRICE IMPACT ANALYSIS 78
5.12.4 IMPACT ON COUTRY/REGION 79
5.12.5 IMPACT ON END USE INDUSTRIES 81
5.12.5.1 Pharmaceutical companies 81
5.12.5.2 Biotechnology companies 81
5.12.5.3 Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) 81
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 82
6.1 TECHNOLOGY ANALYSIS 82
6.1.1 KEY EMERGING TECHNOLOGIES 82
6.1.1.1 Machine vision technology 82
6.1.2 COMPLEMENTARY TECHNOLOGIES 83
6.1.2.1 Advanced sensors & imaging techniques 83
6.1.3 TECHNOLOGY/PRODUCT ROADMAP 83
6.2 PATENT ANALYSIS 85
6.2.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTION FOR PHARMACEUTICAL INSPECTION SYSTEMS, JANUARY 2015–APRIL 2026 85
6.2.2 LIST OF MAJOR PATENTS, 2023–2026 87
6.3 FUTURE APPLICATIONS 88
6.3.1 AI-POWERED VISUAL DEFECT DETECTION 88
6.3.2 ADVANCED HYPERSPECTRAL & MULTI-IMAGING INSPECTION 88
6.3.3 SMART SENSOR-INTEGRATED INSPECTION SYSTEMS 88
6.3.4 INTEGRATED MULTI-FUNCTION PHARMACEUTICAL INSPECTION PLATFORMS 89
6.4 IMPACT OF AI ON PHARMACEUTICAL INSPECTION MACHINES MARKET 89
6.4.1 TOP USE CASES & MARKET POTENTIAL 90
6.4.2 BEST PRACTICES IN PHARMACEUTICAL INSPECTION MACHINES MARKET 90
6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL INSPECTION MACHINES MARKET 91
6.4.4 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 92
6.4.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL INSPECTION MACHINES MARKET 93
7 SUSTAINABILITY & REGULATORY LANDSCAPE 94
7.1 REGIONAL REGULATIONS & COMPLIANCE 94
7.1.1 REGULATORY ANALYSIS 94
7.1.1.1 North America 94
7.1.1.2 Europe 94
7.1.1.3 APAC 95
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
7.2 INDUSTRY STANDARDS 98
7.2.1 PHARMACEUTICAL INSPECTION MACHINE PRACTICE STANDARDS 98
7.2.2 ELECTRICAL AND MACHINERY SAFETY STANDARD – ISO 12100 & EN 60204-1 98
7.2.3 SOFTWARE LIFECYCLE STANDARD – GAMP 5 & FDA 21 CFR PART 11 98
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 99
8.1 DECISION-MAKING PROCESS 99
8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA 99
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 99
8.2.2 KEY BUYING CRITERIA 101
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 101
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 102
8.5 MARKET PROFITABILITY 102
8.5.1 REVENUE POTENTIAL 103
8.5.2 COST DYNAMICS 103
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 103
9 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT 105
9.1 INTRODUCTION 106
9.2 PHARMACEUTICAL INSPECTION SYSTEMS 106
9.2.1 VISION INSPECTION SYSTEMS 108
9.2.1.1 Multifunctional vision inspection systems 111
9.2.1.1.1 Versatility and improved production efficiency to drive segmental growth 111
9.2.1.2 Specialized vision inspection systems 112
9.2.1.2.1 Stringent quality standards and better patient well-being to propel segment growth 112
9.2.2 X-RAY INSPECTION SYSTEMS 113
9.2.2.1 Increasing demand for precise underfill and overfill inspection to aid market growth 113
9.2.3 LEAK DETECTION SYSTEMS 116
9.2.3.1 Rising adoption in pharmaceutical applications to drive market growth 116
9.2.4 METAL DETECTORS 118
9.2.4.1 Growing need for metal contaminant detection in food & beverage industry to boost demand 118
9.2.5 CHECKWEIGHERS 120
9.2.5.1 Increased focus on reducing waste in manufacturing process to aid market growth 120
9.2.6 COMBINATION SYSTEMS 122
9.2.6.1 Technological advancements for ensuring thorough quality assessment and regulatory compliance to drive market 122
9.2.7 OTHER PHARMACEUTICAL INSPECTION SYSTEMS 124
9.3 PHARMACEUTICAL INSPECTION SOFTWARE 125
9.3.1 RISING NEED TO IMPROVE INSPECTION EFFICIENCY TO PROPEL ADOPTION 125
10 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE 128
10.1 INTRODUCTION 129
10.2 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES 129
10.2.1 SUPERIOR THROUGHPUT RATES AND DEFECT DETECTION ACCURACY IN HIGH-VISCOSITY SUSPENSIONS TO DRIVE MARKET 129
10.3 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES 131
10.3.1 SIMULTANEOUS INSPECTION CAPABILITIES WITH HIGH STANDARDS OF PHARMACEUTICAL QUALITY CONTROL TO AID MARKET GROWTH 131
10.4 MANUAL PHARMACEUTICAL INSPECTION MACHINES 133
10.4.1 COST-EFFECTIVENESS TO AUGMENT SEGMENT GROWTH 133
11 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE 135
11.1 INTRODUCTION 136
11.2 AMPOULES & VIALS 136
11.2.1 INCREASING DEMAND FOR VACCINES AND BIOPHARMACEUTICALS TO FUEL MARKET GROWTH 136
11.3 SYRINGES 138
11.3.1 IMPROVED SAFETY AND INCREASED COMPLIANCE WITH CGMP STANDARDS TO SUPPORT MARKET GROWTH 138
11.4 BOTTLES 139
11.4.1 RISING DEMAND FOR LIQUID OR SOLID RESIDUE DETECTION TO AUGMENT MARKET GROWTH 139
11.5 BLISTERS 141
11.5.1 SUPERIOR PRODUCT PROTECTION AND ENHANCED PATIENT COMPLIANCE TO BOOST MARKET GROWTH 141
11.6 OTHER PACKAGING TYPES 142
12 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION 144
12.1 INTRODUCTION 145
12.2 ORAL FORMULATIONS 145
12.2.1 TABLETS & CAPSULES 147
12.2.1.1 Increasing applications in pharmaceutical industry to drive segment 147
12.2.2 ORAL SOLUTIONS & SUSPENSIONS/SYRUPS 148
12.2.2.1 Focus on improved product quality and prevention of contamination to fuel segment growth 148
12.2.3 OTHER ORAL FORMULATIONS 149
12.3 PARENTERAL FORMULATIONS 151
12.3.1 INCREASED PRODUCTION THROUGHPUT AND REDUCED HUMAN ERRORS TO BOOST SEGMENT GROWTH 151
12.4 OTHER FORMULATIONS 152
13 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER 154
13.1 INTRODUCTION 155
13.2 PHARMACEUTICAL COMPANIES 155
13.2.1 HIGH PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 155
13.3 BIOTECHNOLOGY COMPANIES 157
13.3.1 FOCUS ON REDUCING COUNTERFEIT DRUG PRODUCTION AND IMPROVING PRODUCT QUALITY TO SPUR MARKET GROWTH 157
13.4 CROS & CDMOS 159
13.4.1 LOW MANUFACTURING COSTS AND HIGH-QUALITY MAINTENANCE TO FUEL MARKET GROWTH 159
14 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION 161
14.1 INTRODUCTION 162
14.2 NORTH AMERICA 162
14.2.1 US 168
14.2.1.1 US to dominate North American pharmaceutical inspection machines market during forecast period 168
14.2.2 CANADA 172
14.2.2.1 Focus on better healthcare quality and increased patient safety to support market growth 172
14.3 EUROPE 176
14.3.1 GERMANY 180
14.3.1.1 High healthcare spending and presence of key pharmaceutical manufacturers to aid market growth 180
14.3.2 UK 184
14.3.2.1 Rising demand for personalized medicines and increasing geriatric population to augment market growth 184
14.3.3 FRANCE 188
14.3.3.1 Growth in generic drug market and increased pharmaceutical exports to spur adoption 188
14.3.4 ITALY 192
14.3.4.1 Favorable government initiatives and increased private investments to drive market 192
14.3.5 SPAIN 196
14.3.5.1 Improved healthcare infrastructure and high prevalence of chronic diseases to boost market growth 196
14.3.6 REST OF EUROPE 200
14.4 ASIA PACIFIC 204
14.4.1 CHINA 209
14.4.1.1 Increased investment in healthcare infrastructure to propel market growth 209
14.4.2 JAPAN 213
14.4.2.1 Well-developed pharmaceutical manufacturing industry and stringent healthcare regulations to drive market 213
14.4.3 INDIA 217
14.4.3.1 Growing focus on cost-effective branded drug production to fuel market growth 217
14.4.4 AUSTRALIA 221
14.4.4.1 High R&D expenditure and technological advancements to fuel market growth 221
14.4.5 SOUTH KOREA 225
14.4.5.1 Attractive medical tourism industry and favorable government policies to propel market growth 225
14.4.6 REST OF ASIA PACIFIC 229
14.5 LATIN AMERICA 233
14.5.1 BRAZIL 237
14.5.1.1 Increasing geriatric population and rising per capita income to aid market growth 237
14.5.2 MEXICO 241
14.5.2.1 Improving healthcare infrastructure and burgeoning pharmaceutical industry to augment market growth 241
14.5.3 REST OF LATIN AMERICA 245
14.6 MIDDLE EAST & AFRICA 249
14.6.1 GCC COUNTRIES 252
14.6.1.1 Robust economic growth and high public healthcare spending to support market growth 252
15 COMPETITIVE LANDSCAPE 257
15.1 OVERVIEW 257
15.2 KEY PLAYER STRATEGY/RIGHT TO WIN 257
15.3 REVENUE ANALYSIS, 2023–2025 259
15.4 MARKET SHARE ANALYSIS, 2025 260
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 262
15.5.1 STARS 262
15.5.2 EMERGING LEADERS 262
15.5.3 PERVASIVE PLAYERS 262
15.5.4 PARTICIPANTS 262
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 264
15.5.5.1 Company footprint 264
15.5.5.2 Region footprint 265
15.5.5.3 Component footprint 265
15.5.5.4 Type footprint 266
15.5.5.5 Packaging type footprint 267
15.6 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2025 267
15.6.1 PROGRESSIVE COMPANIES 267
15.6.2 RESPONSIVE COMPANIES 267
15.6.3 DYNAMIC COMPANIES 268
15.6.4 STARTING BLOCKS 268
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 269
15.6.5.1 Detailed list of key startups/SMEs 269
15.6.5.2 Competitive benchmarking of key startups/SMEs 269
15.7 COMPANY VALUATION & FINANCIAL METRICS 270
15.7.1 FINANCIAL METRICS 270
15.7.2 COMPANY VALUATION 270
15.8 BRAND/PRODUCT COMPARISON 271
15.9 COMPETITIVE SCENARIO 272
15.9.1 PRODUCT LAUNCHES 272
15.9.2 DEALS 273
15.9.3 EXPANSIONS 274
15.9.4 OTHER DEVELOPMENTS 274
16 COMPANY PROFILES 275
16.1 KEY PLAYERS 275
16.1.1 KÖRBER AG 275
16.1.1.1 Business overview 275
16.1.1.2 Products offered 276
16.1.1.3 Recent developments 278
16.1.1.3.1 Product launches 278
16.1.1.3.2 Deals 278
16.1.1.4 MnM view 279
16.1.1.4.1 Right to win 279
16.1.1.4.2 Strategic choices 279
16.1.1.4.3 Weaknesses & competitive threats 279
16.1.2 METTLER-TOLEDO 280
16.1.2.1 Business overview 280
16.1.2.2 Products offered 281
16.1.2.3 Recent developments 284
16.1.2.3.1 Product launches 284
16.1.2.4 MnM view 285
16.1.2.4.1 Right to win 285
16.1.2.4.2 Strategic choices 285
16.1.2.4.3 Weaknesses & competitive threats 285
16.1.3 OMRON CORPORATION 286
16.1.3.1 Business overview 286
16.1.3.2 Products offered 287
16.1.3.3 Recent developments 288
16.1.3.3.1 Product launches & upgrades 288
16.1.3.3.2 Deals 289
16.1.3.4 MnM view 289
16.1.3.4.1 Right to win 289
16.1.3.4.2 Strategic choices 290
16.1.3.4.3 Weaknesses & competitive threats 290
16.1.4 STEVANATO GROUP 291
16.1.4.1 Business overview 291
16.1.4.2 Products offered 292
16.1.4.3 Recent developments 293
16.1.4.3.1 Product launches & upgrades 293
16.1.4.3.2 Deals 294
16.1.4.4 MnM view 294
16.1.4.4.1 Right to win 294
16.1.4.4.2 Strategic choices 294
16.1.4.4.3 Weaknesses & competitive threats 294
16.1.5 COGNEX CORPORATION 295
16.1.5.1 Business overview 295
16.1.5.2 Products offered 296
16.1.5.3 Recent developments 297
16.1.5.3.1 Product launches 297
16.1.5.3.2 Deals 297
16.1.5.4 MnM view 298
16.1.5.4.1 Right to win 298
16.1.5.4.2 Strategic choices 298
16.1.5.4.3 Weaknesses & competitive threats 298
16.1.6 ANTARES VISION GROUP 299
16.1.6.1 Business overview 299
16.1.6.2 Products offered 300
16.1.6.3 Recent developments 302
16.1.6.3.1 Product launches & upgrades 302
16.1.6.3.2 Deals 303
16.1.6.3.3 Expansion 304
16.1.6.3.4 Other developments 304
16.1.7 OPTEL GROUP 305
16.1.7.1 Business overview 305
16.1.7.2 Products offered 305
16.1.8 SYNTEGON TECHNOLOGY GMBH 307
16.1.8.1 Business overview 307
16.1.8.2 Products offered 307
16.1.8.3 Recent developments 309
16.1.8.3.1 Product launches 309
16.1.9 JEKSON VISION 310
16.1.9.1 Business overview 310
16.1.9.2 Products offered 310
16.1.10 ACG 312
16.1.10.1 Business overview 312
16.1.10.2 Products offered 312
16.1.11 BREVETTI CEA SPA 314
16.1.11.1 Business overview 314
16.1.11.2 Products offered 314
16.1.11.3 Recent developments 316
16.1.11.3.1 Deals 316
16.1.12 ROQUETTE FRÈRES 317
16.1.12.1 Business overview 317
16.1.12.2 Products offered 317
16.1.13 TOFFLON LIFE SCIENCE 319
16.1.13.1 Business overview 319
16.1.13.2 Products offered 319
16.1.14 PRODITEC 320
16.1.14.1 Business overview 320
16.1.14.2 Products offered 320
16.1.15 WIPOTEC GMBH 322
16.1.15.1 Business overview 322
16.1.15.2 Products offered 322
16.1.16 CMP PHARMA S.R.L. 324
16.1.16.1 Business overview 324
16.1.16.2 Products offered 324
16.1.16.3 Recent developments 326
16.1.16.3.1 Expansions 326
16.2 OTHER PLAYERS 327
16.2.1 KEYENCE CORPORATION 327
16.2.2 CASSEL MESSTECHNIK GMBH 328
16.2.3 THERMO FISHER SCIENTIFIC INC. 329
16.2.4 LOMA SYSTEMS 330
16.2.5 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH 330
16.2.6 MINEBEA INTEC GMBH 331
16.2.7 MARCHESINI GROUP S.P.A. 332
16.2.8 N.K.P. PHARMA PVT. LTD. 333
16.2.9 SPAN SYSTEMS 333
17 RESEARCH METHODOLOGY 334
17.1 RESEARCH DATA 334
17.1.1 SECONDARY DATA 334
17.1.1.1 Key data from secondary sources 336
17.1.2 PRIMARY DATA 337
17.1.2.1 Key data from primary sources 338
17.1.2.2 Key industry insights 338
17.2 MARKET SIZE ESTIMATION 339
17.3 MARKET BREAKDOWN & DATA TRIANGULATION 345
17.4 MARKET RANKING ANALYSIS 346
17.5 STUDY ASSUMPTIONS 346
17.6 RISK ASSESSMENT 346
17.7 LIMITATIONS 346
17.7.1 METHODOLOGY-RELATED LIMITATIONS 346
18 APPENDIX 347
18.1 DISCUSSION GUIDE 347
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 351
18.3 CUSTOMIZATION OPTIONS 353
18.4 RELATED REPORTS 353
18.5 AUTHOR DETAILS 354

LIST OF TABLES

TABLE 1 PHARMACEUTICAL INSPECTION MACHINES MARKET: INCLUSIONS & EXCLUSIONS 34
TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD) 35
TABLE 3 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 55
TABLE 4 PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS 57
TABLE 5 GDP CHANGE, BY KEY COUNTRY, 2023–2030 (USD BILLION) 59
TABLE 6 PHARMACEUTICAL INSPECTION MACHINES MARKET: ROLE IN SUPPLY CHAIN 63
TABLE 7 PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS: ROLE IN ECOSYSTEM 66
TABLE 8 END USERS: ROLE IN ECOSYSTEM 67
TABLE 9 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY PRODUCT, 2023–2025 68
TABLE 10 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY END-USE INDUSTRY, 2023–2025 69
TABLE 11 IMPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2021–2025 (THOUSAND USD) 70
TABLE 12 EXPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2021–2025 (THOUSAND USD) 70
TABLE 13 IMPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE: 903190), 2021–2025 (USD) 71
TABLE 14 EXPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING (HS CODE-903190), 2021–2025 (USD) 71
TABLE 15 PHARMACEUTICAL INSPECTION MACHINES MARKET: KEY CONFERENCES & EVENTS, MAY 2026–DECEMBER 2027 72
TABLE 16 CASE STUDY 1: IMPROVING CATTLE HEALTH & REPRODUCTIVE OUTCOMES WITH HIGH-RESOLUTION ULTRASOUND 74
TABLE 17 CASE STUDY 2: INTEGRATED SERIALIZATION & INSPECTION FOR BIOLOGICS MANUFACTURING 75
TABLE 18 CASE STUDY 3: NON-DESTRUCTIVE CONTAINER CLOSURE INTEGRITY TESTING (CCIT) FOR STERILE PHARMACEUTICALS 75
TABLE 19 US-ADJUSTED RECIPROCAL TARIFF RATES 77
TABLE 20 KEY PRODUCT-RELATED TARIFFS 77
TABLE 21 CANADA: IMPACT DUE TO US TARIFFS 79
TABLE 22 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 79
TABLE 23 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 80
TABLE 24 TECHNOLOGY/PRODUCT ROADMAP FOR PHARMACEUTICAL INSPECTION MACHINES MARKET (2026–2035) 84
TABLE 25 PHARMACEUTICAL INSPECTION MACHINES MARKET: LIST OF MAJOR PATENTS, JANUARY 2023–APRIL 2026 87
TABLE 26 KEY COMPANIES IMPLEMENTING AI IN PHARMACEUTICAL INSPECTION MACHINES MARKET 90
TABLE 27 BEST PRACTICES IN PHARMACEUTICAL INSPECTION MACHINES MARKET 90
TABLE 28 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL INSPECTION MACHINES MARKET 91
TABLE 29 INTERCONNECTED ADJACENT ECOSYSTEM & IMPACT ON MARKET PLAYERS 92
TABLE 30 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 31 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 32 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 33 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 34 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 100
TABLE 36 KEY BUYING CRITERIA FOR TOP THREE END USERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET 101
TABLE 37 PHARMACEUTICAL INSPECTION MACHINES MARKET: UNMET NEEDS/END-USER EXPECTATIONS 102
TABLE 38 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 106
TABLE 39 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 107
TABLE 40 PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 108
TABLE 41 LIST OF KEY VISION INSPECTION SYSTEMS AVAILABLE IN MARKET 109
TABLE 42 VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 110
TABLE 43 VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 110
TABLE 44 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR VISION INSPECTION SYSTEMS, BY REGION, 2024–2031 (UNITS) 111
TABLE 45 MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 112
TABLE 46 SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 113
TABLE 47 LIST OF KEY X-RAY INSPECTION SYSTEMS AVAILABLE IN MARKET 114
TABLE 48 X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 115
TABLE 49 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR X-RAY INSPECTION SYSTEMS, BY REGION, 2024–2031 (UNITS) 115
TABLE 50 LIST OF KEY LEAK DETECTION SYSTEMS AVAILABLE IN MARKET 116
TABLE 51 LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 52 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR LEAK DETECTION SYSTEMS, BY REGION, 2024–2031 (UNITS) 117
TABLE 53 LIST OF KEY METAL DETECTORS AVAILABLE IN MARKET 118
TABLE 54 METAL DETECTORS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119
TABLE 55 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR METAL DETECTORS, BY REGION, 2024–2031 (UNITS) 119
TABLE 56 KEY CHECKWEIGHERS AVAILABLE IN MARKET 120
TABLE 57 CHECKWEIGHERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 58 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR CHECKWEIGHERS, BY REGION, 2024–2031 (UNITS) 122
TABLE 59 KEY COMBINATION SYSTEMS AVAILABLE IN MARKET 123
TABLE 60 COMBINATION SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123
TABLE 61 PHARMACEUTICAL INSPECTION MACHINES MARKET VOLUME FOR COMBINATION SYSTEMS, BY REGION, 2024–2031 (UNITS) 124
TABLE 62 OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 125
TABLE 63 KEY PHARMACEUTICAL INSPECTION SOFTWARE AVAILABLE IN MARKET 126
TABLE 64 PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 127
TABLE 65 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 129
TABLE 66 FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 131
TABLE 67 SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 133
TABLE 68 MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 69 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE,
2024–2031 (USD MILLION) 136
TABLE 70 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS,
BY COUNTRY, 2024–2031 (USD MILLION) 137
TABLE 71 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2024–2031 (USD MILLION) 139
TABLE 72 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2024–2031 (USD MILLION) 140
TABLE 73 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY REGION, 2024–2031 (USD MILLION) 142
TABLE 74 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 75 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 145
TABLE 76 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 146
TABLE 77 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 146
TABLE 78 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR TABLETS & CAPSULES, BY COUNTRY, 2024–2031 (USD MILLION) 148
TABLE 79 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL SOLUTIONS & SUSPENSIONS/SYRUPS, BY COUNTRY, 2024–2031 (USD MILLION) 149
TABLE 80 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER ORAL FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 150
TABLE 81 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 152
TABLE 82 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 153
TABLE 83 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,
2024–2031 (USD MILLION) 155
TABLE 84 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 156
TABLE 85 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 158
TABLE 86 PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS,
BY COUNTRY, 2024–2031 (USD MILLION) 160
TABLE 87 PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION,
2024–2031 (USD MILLION) 162
TABLE 88 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 164
TABLE 89 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 164
TABLE 90 NORTH AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 165
TABLE 91 NORTH AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 165
TABLE 92 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 166
TABLE 93 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 166
TABLE 94 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 167
TABLE 95 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 167
TABLE 96 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 167
TABLE 97 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 168
TABLE 98 US: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 169
TABLE 99 US: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 169
TABLE 100 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 170
TABLE 101 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 170
TABLE 102 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 171
TABLE 103 US: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 104 US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,
2024–2031 (USD MILLION) 171
TABLE 105 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 172
TABLE 106 CANADA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 173
TABLE 107 CANADA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 173
TABLE 108 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 174
TABLE 109 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 174
TABLE 110 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 175
TABLE 111 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 175
TABLE 112 CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 175
TABLE 113 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 176
TABLE 114 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 177
TABLE 115 EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 177
TABLE 116 EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 178
TABLE 117 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 178
TABLE 118 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 178
TABLE 119 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 179
TABLE 120 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 179
TABLE 121 EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 179
TABLE 122 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 181
TABLE 123 GERMANY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 181
TABLE 124 GERMANY: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 182
TABLE 125 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 182
TABLE 126 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 182
TABLE 127 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 183
TABLE 128 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 183
TABLE 129 GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 183
TABLE 130 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,
2024–2031 (USD MILLION) 184
TABLE 131 UK: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 185
TABLE 132 UK: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 185
TABLE 133 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 186
TABLE 134 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 186
TABLE 135 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 187
TABLE 136 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 187
TABLE 137 UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,
2024–2031 (USD MILLION) 187
TABLE 138 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 188
TABLE 139 FRANCE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 189
TABLE 140 FRANCE: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 189
TABLE 141 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 190
TABLE 142 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 190
TABLE 143 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 191
TABLE 144 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 191
TABLE 145 FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 191
TABLE 146 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 192
TABLE 147 ITALY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 148 ITALY: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 193
TABLE 149 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 194
TABLE 150 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 194
TABLE 151 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 195
TABLE 152 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 153 ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,
2024–2031 (USD MILLION) 195
TABLE 154 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 196
TABLE 155 SPAIN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 156 SPAIN: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 157 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 198
TABLE 158 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 198
TABLE 159 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 199
TABLE 160 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 199
TABLE 161 SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,
2024–2031 (USD MILLION) 199
TABLE 162 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 200
TABLE 163 REST OF EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 201
TABLE 164 REST OF EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 165 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 202
TABLE 166 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 202
TABLE 167 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 203
TABLE 168 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 169 REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 203
TABLE 170 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205
TABLE 171 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 206
TABLE 172 ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 206
TABLE 173 ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 174 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 207
TABLE 175 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 208
TABLE 176 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 208
TABLE 177 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 178 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 209
TABLE 179 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 210
TABLE 180 CHINA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 181 CHINA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 182 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 211
TABLE 183 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 211
TABLE 184 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 212
TABLE 185 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 212
TABLE 186 CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 212
TABLE 187 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 213
TABLE 188 JAPAN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 189 JAPAN: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 190 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 191 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 215
TABLE 192 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 216
TABLE 193 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 216
TABLE 194 JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 216
TABLE 195 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 217
TABLE 196 INDIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 197 INDIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 218
TABLE 198 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 199 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 219
TABLE 200 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 220
TABLE 201 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 220
TABLE 202 INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,
2024–2031 (USD MILLION) 220
TABLE 203 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 221
TABLE 204 AUSTRALIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 222
TABLE 205 AUSTRALIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 222
TABLE 206 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 207 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 223
TABLE 208 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 224
TABLE 209 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 224
TABLE 210 AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 224
TABLE 211 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 225
TABLE 212 SOUTH KOREA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 213 SOUTH KOREA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 226
TABLE 214 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 215 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 227
TABLE 216 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 228
TABLE 217 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 228
TABLE 218 SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 228
TABLE 219 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 229
TABLE 220 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 230
TABLE 221 REST OF ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 230
TABLE 222 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 231
TABLE 223 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 231
TABLE 224 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 232
TABLE 225 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 226 REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY END USER, 2024–2031 (USD MILLION) 232
TABLE 227 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COUNTRY, 2024–2031 (USD MILLION) 233
TABLE 228 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 233
TABLE 229 LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 234
TABLE 230 LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 234
TABLE 231 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 235
TABLE 232 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 235
TABLE 233 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 236
TABLE 234 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 236
TABLE 235 LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 236
TABLE 236 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 237
TABLE 237 BRAZIL: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 238
TABLE 238 BRAZIL: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 238
TABLE 239 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 240 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 239
TABLE 241 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 240
TABLE 242 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 243 BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 241
TABLE 244 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 242
TABLE 245 MEXICO: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 242
TABLE 246 MEXICO: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 247 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 248 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2024–2031 (USD MILLION) 243
TABLE 249 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 244
TABLE 250 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 244
TABLE 251 MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 244
TABLE 252 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 245
TABLE 253 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 246
TABLE 254 REST OF LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 255 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 247
TABLE 256 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 247
TABLE 257 EST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 248
TABLE 258 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 259 REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY END USER, 2024–2031 (USD MILLION) 248
TABLE 260 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 249
TABLE 261 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 262 MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 263 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY TYPE, 2024–2031 (USD MILLION) 250
TABLE 264 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 251
TABLE 265 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 251
TABLE 266 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 267 MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY END USER, 2024–2031 (USD MILLION) 252
TABLE 268 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY COMPONENT, 2024–2031 (USD MILLION) 253
TABLE 269 GCC COUNTRIES: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 254
TABLE 270 GCC COUNTRIES: VISION INSPECTION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 254
TABLE 271 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2024–2031 (USD MILLION) 255
TABLE 272 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY PACKAGING TYPE, 2024–2031 (USD MILLION) 255
TABLE 273 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,
BY FORMULATION, 2024–2031 (USD MILLION) 256
TABLE 274 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2024–2031 (USD MILLION) 256
TABLE 275 GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2024–2031 (USD MILLION) 256
TABLE 276 KEY DEVELOPMENTS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, JANUARY 2021–MAY 2026 257
TABLE 277 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEGREE OF COMPETITION 260
TABLE 278 PHARMACEUTICAL INSPECTION MACHINES MARKET: REGION FOOTPRINT 265
TABLE 279 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPONENT FOOTPRINT 265
TABLE 280 PHARMACEUTICAL INSPECTION MACHINES MARKET: TYPE FOOTPRINT 266
TABLE 281 PHARMACEUTICAL INSPECTION MACHINES MARKET: PACKAGING TYPE FOOTPRINT 267
TABLE 282 PHARMACEUTICAL INSPECTION MACHINES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 269
TABLE 283 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 269
TABLE 284 PHARMACEUTICAL INSPECTION MACHINES MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 272
TABLE 285 PHARMACEUTICAL INSPECTION MACHINES MARKET: DEALS,
JANUARY 2022–MAY 2026 273
TABLE 286 PHARMACEUTICAL INSPECTION MACHINES MARKET: EXPANSIONS,
JANUARY 2022–MAY 2026 274
TABLE 287 PHARMACEUTICAL INSPECTION MACHINES MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MAY 2026 274
TABLE 288 KÖRBER AG: COMPANY OVERVIEW 275
TABLE 289 KÖRBER AG: PRODUCTS OFFERED 276
TABLE 290 KÖRBER AG: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 278
TABLE 291 KÖRBER AG: DEALS, JANUARY 2022–MAY 2026 278
TABLE 292 METTLER-TOLEDO: COMPANY OVERVIEW 280
TABLE 293 METTLER-TOLEDO: PRODUCTS OFFERED 281
TABLE 294 METTLER-TOLEDO: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 284
TABLE 295 OMRON CORPORATION: COMPANY OVERVIEW 286
TABLE 296 OMRON CORPORATION: PRODUCTS OFFERED 287
TABLE 297 OMRON CORPORATION: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2022–MAY 2026 288
TABLE 298 OMRON CORPORATION: DEALS, JANUARY 2022–MAY 2026 289
TABLE 299 STEVANATO GROUP: COMPANY OVERVIEW 291
TABLE 300 STEVANATO GROUP: PRODUCTS OFFERED 292
TABLE 301 STEVANATO GROUP: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2022–MAY 2026 293
TABLE 302 STEVANATO GROUP: DEALS, JANUARY 2022–MAY 2026 294
TABLE 303 COGNEX CORPORATION: COMPANY OVERVIEW 295
TABLE 304 COGNEX CORPORATION: PRODUCTS OFFERED 296
TABLE 305 COGNEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–MAY 2026 297
TABLE 306 COGNEX CORPORATION: DEALS, JANUARY 2022–MAY 2026 297
TABLE 307 ANTARES VISION GROUP: COMPANY OVERVIEW 299
TABLE 308 ANTARES VISION GROUP: PRODUCTS OFFERED 300
TABLE 309 ANTARES VISION GROUP: PRODUCT LAUNCHES & UPGRADES,
JANUARY 2022–MAY 2026 302
TABLE 310 ANTARES VISION GROUP: DEALS, JANUARY 2022–MAY 2026 303
TABLE 311 ANTARES VISION GROUP: EXPANSION, JANUARY 2022–MAY 2026 304
TABLE 312 ANTARES VISION GROUP: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 304
TABLE 313 OPTEL GROUP: COMPANY OVERVIEW 305
TABLE 314 OPTEL GROUP: PRODUCTS OFFERED 305
TABLE 315 SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW 307
TABLE 316 SYNTEGON TECHNOLOGY GMBH: PRODUCTS OFFERED 307
TABLE 317 SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES,
JANUARY 2022–MAY 2026 309
TABLE 318 JEKSON VISION: COMPANY OVERVIEW 310
TABLE 319 JEKSON VISION: PRODUCTS OFFERED 310
TABLE 320 ACG: COMPANY OVERVIEW 312
TABLE 321 ACG: PRODUCTS OFFERED 312
TABLE 322 BREVETTI CEA SPA: COMPANY OVERVIEW 314
TABLE 323 BREVETTI CEA SPA: PRODUCTS OFFERED 314
TABLE 324 BREVETTI CEA SPA: DEALS, JANUARY 2022–MAY 2026 316
TABLE 325 ROQUETTE FRÈRES: COMPANY OVERVIEW 317
TABLE 326 ROQUETTE FRÈRES: PRODUCTS OFFERED 317
TABLE 327 TOFFLON LIFE SCIENCE: COMPANY OVERVIEW 319
TABLE 328 TOFFLON LIFE SCIENCE: PRODUCTS OFFERED 319
TABLE 329 PRODITEC: COMPANY OVERVIEW 320
TABLE 330 PRODITEC: PRODUCTS OFFERED 320
TABLE 331 WIPOTEC GMBH: COMPANY OVERVIEW 322
TABLE 332 WIPOTEC GMBH: PRODUCTS OFFERED 322
TABLE 333 CMP PHARMA S.R.L.: COMPANY OVERVIEW 324
TABLE 334 CMP PHARMA S.R.L.: PRODUCTS OFFERED 324
TABLE 335 CMP PHARMA S.R.L.: EXPANSIONS, JANUARY 2021–MAY 2026 326
TABLE 336 KEYENCE CORPORATION: COMPANY OVERVIEW 327
TABLE 337 CASSEL MESSTECHNIK GMBH: COMPANY OVERVIEW 328
TABLE 338 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 329
TABLE 339 LOMA SYSTEMS: COMPANY OVERVIEW 330
TABLE 340 VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH: COMPANY OVERVIEW 330
TABLE 341 MINEBEA INTEC GMBH: COMPANY OVERVIEW 331
TABLE 342 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW 332
TABLE 343 N.K.P. PHARMA PVT. LTD.: COMPANY OVERVIEW 333
TABLE 344 SPAN SYSTEMS: COMPANY OVERVIEW 333

LIST OF FIGURES

FIGURE 1 PHARMACEUTICAL INSPECTION MACHINES MARKET SEGMENTATION & REGIONAL SCOPE 33
FIGURE 2 PHARMACEUTICAL INSPECTION MACHINES MARKET: YEARS CONSIDERED 34
FIGURE 3 KEY INSIGHTS & MARKET HIGHLIGHTS 37
FIGURE 4 PHARMACEUTICAL INSPECTION MACHINES MARKET, 2026–2031 38
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET 39
FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF PHARMACEUTICAL INSPECTION MACHINES MARKET 40
FIGURE 7 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, 2026 41
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 42
FIGURE 9 STRINGENT REGULATORY FRAMEWORK IN BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH 43
FIGURE 10 PHARMACEUTICAL INSPECTION SYSTEMS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2025 44
FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2026 TO 2031 45
FIGURE 12 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2031 45
FIGURE 13 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE 46
FIGURE 14 PHARMACEUTICAL INSPECTION MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
FIGURE 15 PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS 57
FIGURE 16 PHARMACEUTICAL INSPECTION MACHINES MARKET: SUPPLY CHAIN ANALYSIS 62
FIGURE 17 PHARMACEUTICAL INSPECTION MACHINES MARKET: VALUE CHAIN ANALYSIS 65
FIGURE 18 PHARMACEUTICAL INSPECTION MACHINES MARKET: ECOSYSTEM ANALYSIS 66
FIGURE 19 AVERAGE SELLING PRICE TREND FOR PHARMACEUTICAL INSPECTION MACHINES, BY REGION (USD THOUSAND) 69
FIGURE 20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 21 PHARMACEUTICAL INSPECTION MACHINES MARKET: INVESTMENT & FUNDING SCENARIO 74
FIGURE 22 PATENT PUBLICATION TRENDS, JURISDICTION, AND TOP APPLICANT ANALYSIS (JANUARY 2015–DECEMBER 2025) 86
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR PHARMACEUTICAL INSPECTION MACHINES (JANUARY 2015–DECEMBER 2025) 87
FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL INSPECTION MACHINE PRODUCTS 100
FIGURE 25 KEY BUYING CRITERIA FOR PHARMACEUTICAL INSPECTION MACHINE PRODUCTS 101
FIGURE 26 NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT 163
FIGURE 27 ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT 205
FIGURE 28 REVENUE ANALYSIS OF TOP PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, 2023–2025 (USD MILLION) 259
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET, 2025 260
FIGURE 30 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 263
FIGURE 31 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY FOOTPRINT 264
FIGURE 32 PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 268
FIGURE 33 EV/EBITDA OF KEY VENDORS 270
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 270
FIGURE 35 PHARMACEUTICAL INSPECTION MACHINES MARKET: BRAND/PRODUCT COMPARISON 271
FIGURE 36 KÖRBER AG: COMPANY SNAPSHOT (2025) 276
FIGURE 37 METTLER-TOLEDO: COMPANY SNAPSHOT (2025) 281
FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2025) 287
FIGURE 39 STEVANATO GROUP: COMPANY SNAPSHOT (2025) 292
FIGURE 40 COGNEX CORPORATION: COMPANY SNAPSHOT (2025) 295
FIGURE 41 ANTARES VISION GROUP: COMPANY SNAPSHOT (2025) 300
FIGURE 42 PHARMACEUTICAL INSPECTION MACHINES MARKET: RESEARCH DESIGN 334
FIGURE 43 PRIMARY SOURCES 337
FIGURE 44 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 339
FIGURE 45 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE & DEMAND-SIDE PARTICIPANTS 339
FIGURE 46 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 340
FIGURE 47 REVENUE SHARE ANALYSIS ILLUSTRATION: KÖRBER AG 340
FIGURE 48 TOP-DOWN APPROACH 341
FIGURE 49 DEMAND-SIDE MARKET ESTIMATION: PHARMACEUTICAL INSPECTION MACHINE, BY APPLICATION 342
FIGURE 50 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031): IMPACT ON MARKET GROWTH AND CAGR 343
FIGURE 51 CAGR PROJECTIONS 344
FIGURE 52 DATA TRIANGULATION METHODOLOGY 345

---

---